LEAD IDENTIFICATION OF HYDROXAMATE DERIVATIVE AS SELECTIVE HDAC2 INHIBITOR USING COMPUTATIONAL APPROACHES
Divya Shirbhate E.(Guru Ghasidas Vishwavidyalaya), Harish Rajak(Guru Ghasidas Vishwavidyalaya), Talha Jawaid(Imam Mohammad ibn Saud Islamic University), Vijay K. Patel(Guru Ghasidas Vishwavidyalaya), Mehnaz Kamal(Prince Sattam Bin Abdulaziz University), Ravichandran Veerasamy(Guru Ghasidas Vishwavidyalaya), Preeti Patel(Indo Soviet Friendship College of Pharmacy)
Cited by 1
Related Papers
Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs
|Life|2023|209
Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention
|Pharmacological Reports|2021|145
A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer
|Drug Delivery and Translational Research|2024|141
Alternatives of Animal Models for Biomedical Research: a Comprehensive Review of Modern Approaches
|Stem Cell Reviews and Reports|2024|85
Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches
|European Journal of Medicinal Chemistry|2021|72